On Friday, the safety committee of the European Union’s decentralized drug regulator — the European Medicines Agency (EMA) — recognized a link between the use of chloroquine and a related compound, hydroxychloroquine, and side effects including psychiatric problems and suicidal behavior. The drugs, which have been used around the globe to treat malaria, were previously championed by President Donald Trump as treatments for COVID-19 before being deemed ineffective.
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) further suggested that the product information of all medicines containing the compounds be updated to inform users of their potentially dangerous side effects.
“The PRAC recommends updating the product information for these medicines to provide better information to healthcare professionals and patients on the risk of suicidal behavior and psychiatric disorders,” stated the report.
Click here to continue and read more…
